Peptide

Pasireotide (Signifor)

FDA-approved product existsGH axis & hormones
Not yet scored

BioHarmony verdict

Awaiting review

No BioHarmony report yet. It is queued for review; until then, rely on the status and sources below.

What is Pasireotide (Signifor)?

FDA-approved pasireotide is marketed as Signifor for specified adults with Cushing disease; a long-acting formulation has a separate label for specified uses.

Dosing as published

Approved labelSIGNIFOR prescribing information for Cushing's disease
PopulationAdults covered by the approved SIGNIFOR indication
DoseInitial dose is 0.6 mg or 0.9 mg twice daily; the labeled range is 0.3-0.9 mg twice daily with response- and tolerability-based titration.
RouteSubcutaneous injection
FrequencyTwice daily
DurationLong-term use within the approved indication with label-directed monitoring
PreparationReady-to-use 0.3 mg/mL, 0.6 mg/mL, or 0.9 mg/mL single-dose ampule; no reconstitution.
Source: Dosage and Administration sections 2.1-2.3; Dosage Forms and Strengths section 3

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

US approvalFDA-approved product exists
CompoundingFDA-approved product exists; compounded copies are not FDA approved
Last checked2026-07-13
Next review2026-10-11

Primary sources

  1. 7.5/10TB-500 (Thymosin Beta-4 Fragment)Strong recommendRecoveryNot FDA approvedTB-500 is a synthetic LKKTETQ fragment marketed for soft-tissue repair, but most human evidence is on full-length topical thymosin beta-4: Sosne 2023 reported corneal…
  2. 6.4/10Kisspeptin-10Worth tryingGH & hormonesNot FDA approvedKisspeptin-10 is an investigational reproductive neuropeptide that activates the HPG axis through the KISS1R receptor.
  3. 6.3/10Gonadorelin (GnRH)Worth tryingGH & hormonesFDA-approved product existsGonadorelin is synthetic GnRH, a decapeptide that tells the pituitary to release LH and FSH.
  4. 6.2/10IpamorelinWorth tryingRecoveryNot FDA approvedIpamorelin is a selective growth-hormone secretagogue with strong receptor selectivity but almost no human efficacy data: its only completed human efficacy trial…

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.